Author

C. G. W. Gertzen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

H. Gohlke· 2 shared A. A. Jaguva Vasudevan· 1 shared A. Sangwiman· 1 shared C. Küstermann· 1 shared C. Münk· 1 shared D. Häussinger· 1 shared D. Steinritz· 1 shared F. Borveto· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

H. Gohlke

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologyToxicology LettersPeer-reviewedFeb 1, 2024

MS Binding Assays with UNC0642 as reporter ligand for the MB327 binding site of the nicotinic acetylcholine receptor

V. Nitsche, G. Hoefner, J. Kaiser…·K. T. Wanner

The paper establishes MS Binding Assays using UNC0642 as a reporter ligand to study the MB327 binding site of the nicotinic acetylcholine receptor, showing its effectiveness in both in vitro and in silico studies.

DOI 10.1016/j.toxlet.2024.01.003

ratexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivFeb 5, 2020

Loop 1 of APOBEC3C regulates its antiviral activity against HIV-1

A. A. Jaguva Vasudevan, K. Balakrishnan, C. G. W. Gertzen…·C. Münk

This study shows that modifying loop 1 residues in APOBEC3C enhances its antiviral activity against HIV-1 and LINE-1 by improving ssDNA binding and deamination.

DOI 10.1016/j.jmb.2020.10.014

humanproteomics

𝕏 PostBluesky